End‐of‐life quality metrics among medicare decedents at minority‐serving cancer centers: A retrospective study
Autor: | Shama S. Alam, Garrett Wasp, Donald Carmichael, Inas S. Khayal, Gabriel A. Brooks, Amber E. Barnato, Andrea M. Austin, Nirav S. Kapadia |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
0301 basic medicine Advance care planning Cancer Research medicine.medical_specialty Palliative care Referral Life quality Cancer Care Facilities Medicare lcsh:RC254-282 law.invention 03 medical and health sciences 0302 clinical medicine law Neoplasms cancer Humans Medicine Radiology Nuclear Medicine and imaging Minority Groups Original Research Aged Quality Indicators Health Care Retrospective Studies end‐of‐life quality Aged 80 and over Terminal Care minority business.industry Cancer Retrospective cohort study treatment intensity Emergency department lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens medicine.disease Intensive care unit United States Hospitalization Benchmarking 030104 developmental biology Oncology 030220 oncology & carcinogenesis Emergency medicine Quality of Life Female business Cancer Prevention |
Zdroj: | Cancer Medicine Cancer Medicine, Vol 9, Iss 5, Pp 1911-1921 (2020) |
ISSN: | 2045-7634 |
DOI: | 10.1002/cam4.2752 |
Popis: | Background We calculated the performance of National Cancer Institute (NCI)/National Comprehensive Cancer Network (NCCN) cancer centers’ end‐of‐life (EOL) quality metrics among minority and white decedents to explore center‐attributable sources of EOL disparities. Methods We conducted a retrospective cohort study of Medicare beneficiaries with poor‐prognosis cancers who died between April 1, 2016 and December 31, 2016 and had any inpatient services in the last 6 months of life. We attributed patients’ EOL treatment to the center at which they received the preponderance of EOL inpatient services and calculated eight risk‐adjusted metrics of EOL quality (hospice admission ≤3 days before death; chemotherapy last 14 days of life; ≥2 emergency department (ED) visits; intensive care unit (ICU) admission; or life‐sustaining treatment last 30 days; hospice referral; palliative care; advance care planning last 6 months). We compared performance between patients across and within centers. Results Among 126,434 patients, 10,119 received treatment at one of 54 NCI/NCCN centers. In aggregate, performance was worse among minorities for ED visits (10.3% vs 7.4%, P We evaluated end‐of‐life quality metrics by minority serving status at NCI/NCCN cancer centers. We found higher minority‐serving status associated with worse end‐of‐life quality on some but not all measures. However, at any given cancer center, care was similar for minority and white patients. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |